retatrutide 2025 trial results clinical status retatrutide trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a clinical trial south africa – ESC 2024: Retatrutide improves lipid Retatrutide is the most significant

US$ 27.85

★★★★★ 4.6 (28 reviews)

US$ 26.30

★★★★★ 5.0 (9 reviews)

US$ 22.07

★★★★★ 4.2 (29 reviews)

US$ 23.60

★★★★★ 4.3 (8 reviews)

US$ 29.26

★★★★★ 4.8 (17 reviews)

US$ 23.07

★★★★★ 4.2 (25 reviews)

US$ 23.58

★★★★★ 4.2 (20 reviews)

US$ 26.10

★★★★★ 4.6 (20 reviews)

US$ 21.59

★★★★★ 4.9 (17 reviews)

US$ 25.92

★★★★★ 4.2 (14 reviews)

US$ 27.58

★★★★★ 4.7 (8 reviews)

US$ 25.28

★★★★★ 4.6 (20 reviews)

US$ 27.49

★★★★★ 4.5 (17 reviews)

US$ 25.25

★★★★★ 4.7 (14 reviews)

US$ 23.08

★★★★★ 4.4 (13 reviews)

US$ 26.07

★★★★★ 4.2 (21 reviews)

US$ 21.81

★★★★★ 4.1 (11 reviews)

US$ 24.06

★★★★★ 4.9 (8 reviews)

US$ 21.74

★★★★★ 4.0 (25 reviews)

US$ 28.17

★★★★★ 5.0 (22 reviews)